Entain PLC (LSE:ENT) received a boost from its 50% owned joint venture BetMGM after the US business raised its full-year EBITDA guidance on the back of strong trading in the second quarter, but analysts at Shore Capital said they did not feel this was being fully reflected in the FTSE 100 group's valuation. BetMGM now expects to deliver at least $150 million in EBITDA for the year, up from the previous $100 million target, as first-half revenue rose 35% to $891 million, with the second quarter up 36%.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Biohaven To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Biohaven between March 24, 2023 and May 14, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Biohaven Ltd.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Replimune between November 22, 2024 and July 21, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. ("Replimune" …

SHAK's second-quarter results are likely to benefit from menu innovation and unit growth. Yet rising costs may weigh on margins.

Camden National (CAC) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.81 per share a year ago.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fortrea Holdings Inc. ("Fortrea" …

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

In recent months, shares of fuel cell systems developer Ballard Power Systems Inc. have rallied by almost 70%. The reinstatement of investment tax credits, announcement of new leadership and momentum traders chasing former hype stocks have contributed to the move. Last week, the company announced "one of the largest marine fuel cell engine orders in history" for two newbuild feeder containerships.

AZN's second-quarter revenues beat on strong drug sales across Oncology and CVRM despite in-line earnings.

VRTX eyes second-quarter growth with surging Trikafta sales. Investors' focus is likely to be on the progress of Casgevy, and Alyftrek and Journavx launches.

Franklin Electric (FELE) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.26 per share a year ago.

Review Teledyne's (TDY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Beyond analysts' top-and-bottom-line estimates for ArcelorMittal (MT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

Besides Wall Street's top-and-bottom-line estimates for Kellanova (K), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

Beyond analysts' top-and-bottom-line estimates for Check Point (CHKP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Markel Group (MKL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Besides Wall Street's top-and-bottom-line estimates for Ameren (AEE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

Evaluate the expected performance of AvalonBay (AVB) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Beyond analysts' top-and-bottom-line estimates for Chevron (CVX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.